MX9704059A - Derivado de amidinonaftilo novedoso o sal del mismo. - Google Patents

Derivado de amidinonaftilo novedoso o sal del mismo.

Info

Publication number
MX9704059A
MX9704059A MX9704059A MX9704059A MX9704059A MX 9704059 A MX9704059 A MX 9704059A MX 9704059 A MX9704059 A MX 9704059A MX 9704059 A MX9704059 A MX 9704059A MX 9704059 A MX9704059 A MX 9704059A
Authority
MX
Mexico
Prior art keywords
amidinonaphthyl derivative
salt
novel
amidinonaphthyl
derivative
Prior art date
Application number
MX9704059A
Other languages
English (en)
Inventor
Fukushi Hirayama
Hiroyuki Koshio
Yuzo Matsumoto
Tomihisa Kawasaki
Seiji Kaku
Isao Yanagisawa
Original Assignee
Yamanouchi Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yamanouchi Pharma Co Ltd filed Critical Yamanouchi Pharma Co Ltd
Publication of MX9704059A publication Critical patent/MX9704059A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40—Oxygen atoms
    • C07D211/44—Oxygen atoms attached in position 4
    • C07D211/46—Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Un derivado de amidinonaftilo representado por la siguiente formula general (I), que tiene una accion inhibidora de la acumulacion de plaquetas basada en la accion inhibidora del factor X de coagulacion sanguínea activado, y es util como un agente contra trombos y similares, una sal del mismo, un intermediario del mismo, y una composicion farmacéutica que comprende al derivado de amidinonaftilo. Un derivado de amidinonaftilo representado por la siguiente formula general (I), o una sal farmacéuticamente aceptable del mismo: (Ver Formula) (los símbolos en la formula tienen los siguientes significados: R1; un átomo de hidrogeno o un grupo representado por la formula -A-W-R4, A: un grupo representado por la formula (Ver Formula) un grupo representado por la formula, o un grupo representado por la formula -SO2-, X: un átomo de oxígeno o un átomo de azufre, W: un enlace sencillo o un grupo representado por la formula -NR5-; R4: un grupo hidroxilo, un grupo alcoxi inferior, etcétera; R5: un átomo de hidrogeno, un grupo carbamoilo, un grupo alcoxi inferior-carbonilo, etcétera; R2: un grupo alquilo inferior, R3: un átomo de hidrogeno, un átomo de halogeno, un grupo carboxilo; B: un grupo alquileno inferior o un grupo carbonilo; y n: 0 o 1.
MX9704059A 1994-12-02 1995-12-01 Derivado de amidinonaftilo novedoso o sal del mismo. MX9704059A (es)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP29996394 1994-12-02
JP10520595 1995-04-28
JP19881695 1995-08-03
PCT/JP1995/002458 WO1996016940A1 (fr) 1994-12-02 1995-12-01 Nouveau derive d'amidinonaphtyle ou sel de celui-ci

Publications (1)

Publication Number Publication Date
MX9704059A true MX9704059A (es) 1997-08-30

Family

ID=27310425

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9704059A MX9704059A (es) 1994-12-02 1995-12-01 Derivado de amidinonaftilo novedoso o sal del mismo.

Country Status (20)

Country Link
US (1) US5869501A (es)
EP (1) EP0798295B1 (es)
JP (1) JP3004362B2 (es)
KR (1) KR100383161B1 (es)
CN (1) CN1087736C (es)
AT (1) ATE233240T1 (es)
AU (1) AU688628B2 (es)
CA (1) CA2206532C (es)
DE (1) DE69529770T2 (es)
ES (1) ES2193202T3 (es)
FI (1) FI115051B (es)
HU (1) HUT77313A (es)
MX (1) MX9704059A (es)
NO (1) NO309566B1 (es)
NZ (1) NZ296210A (es)
PL (1) PL184824B1 (es)
PT (1) PT798295E (es)
RU (1) RU2154633C2 (es)
TW (1) TW300888B (es)
WO (1) WO1996016940A1 (es)

Families Citing this family (64)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0813525T3 (da) 1995-03-10 2004-02-16 Berlex Lab Benzamidinderivater, deres fremstilling og anvendelse som antikoagulanter
SE9602646D0 (sv) * 1996-07-04 1996-07-04 Astra Ab Pharmaceutically-useful compounds
EP0842941A1 (de) 1996-11-16 1998-05-20 Roche Diagnostics GmbH Neue Phosphonate, Verfahren zu ihrer Herstellung und Arzneimittel
US6653340B1 (en) 1997-06-03 2003-11-25 Biocryst Pharmaceuticals, Inc. Compounds useful in the complement, coagulat and kallikrein pathways and method for their preparation
US6060491A (en) * 1997-06-19 2000-05-09 Dupont Pharmaceuticals 6-membered aromatics as factor Xa inhibitors
AU7976998A (en) * 1997-06-19 1999-01-04 Du Pont Merck Pharmaceutical Company, The (amidino)6-membered aromatics as factor xa inhibitors
ZA986594B (en) * 1997-07-25 1999-01-27 Abbott Lab Urokinase inhibitors
US6258822B1 (en) 1997-08-06 2001-07-10 Abbott Laboratories Urokinase inhibitors
WO1999011617A1 (fr) * 1997-09-01 1999-03-11 Yamanouchi Pharmaceutical Co., Ltd. Nouveaux derives de naphtamide et sels de ces derives
US6686364B2 (en) 1997-12-08 2004-02-03 Berlex Laboratories, Inc. Benzamidine derivatives and their use as anti-coagulants
DE19754490A1 (de) * 1997-12-09 1999-06-10 Boehringer Ingelheim Pharma Durch einen Aminocarbonylrest substituierte Bicyclen, ihre Herstellung und ihre Verwendung als Arzneimittel
AU1692399A (en) * 1997-12-26 1999-07-19 Mochida Pharmaceutical Co., Ltd. Aromatic compounds having cyclic amino or salts thereof
AU2074699A (en) * 1998-01-26 1999-08-09 Yamanouchi Pharmaceutical Co., Ltd. Novel benzene-fused heterocyclic derivatives or salts thereof
EP0937723A1 (de) * 1998-02-18 1999-08-25 Roche Diagnostics GmbH Neue Sulfonamide, Verfahren zu ihrer Herstellung sowie diese enthaltende Arzneimittel
EP1066272A4 (en) * 1998-03-27 2002-03-13 Biocryst Pharm Inc NEW CONNECTIONS USEFUL IN THE COMPLEMENT, COAGULATE AND KALLIKREIN REACTION WAY AND METHOD FOR THEIR PRODUCTION
SK15072000A3 (sk) 1998-04-10 2001-08-06 Japan Tobacco Inc. Amidové zlúčeniny
US6504031B1 (en) 1998-08-06 2003-01-07 Milan Bruncko Naphthamidine urokinase inhibitors
US6284796B1 (en) 1998-08-06 2001-09-04 Abbott Laboratories Ukokinase inhibitors
US6262088B1 (en) 1998-11-19 2001-07-17 Berlex Laboratories, Inc. Polyhydroxylated monocyclic N-heterocyclic derivatives as anti-coagulants
CA2320730A1 (en) 1998-12-23 2000-07-06 Renhua Li Thrombin or factor xa inhibitors
ATE307111T1 (de) 1999-01-13 2005-11-15 Genentech Inc Serinprotease-inhibitoren
JP4599714B2 (ja) * 1999-01-22 2010-12-15 アステラス製薬株式会社 経口吸収改善医薬用組成物
JP2002538151A (ja) 1999-03-02 2002-11-12 ベーリンガー インゲルハイム ファーマシューティカルズ インコーポレイテッド カテプシンの可逆的インヒビターとして有用な化合物
FR2793247B1 (fr) * 1999-05-04 2001-06-22 Synthelabo Derives de 6-[[(aryl et heteroaryl)oxy]methyl]naphtalene-2- carboximidamide, leur preparation et leur application en therapeutique
US6858599B2 (en) 1999-06-30 2005-02-22 Mochida Pharmaceutical Co., Ltd. Tricyclic compound having spiro union
WO2001002356A1 (fr) * 1999-07-01 2001-01-11 Sankyo Company, Limited Dérivés d'indoline ou tétrahydroquinoline
US6350761B1 (en) * 1999-07-30 2002-02-26 Berlex Laboratories, Inc. Benzenamine derivatives as anti-coagulants
US6420364B1 (en) 1999-09-13 2002-07-16 Boehringer Ingelheim Pharmaceuticals, Inc. Compound useful as reversible inhibitors of cysteine proteases
AU776193B2 (en) 1999-10-28 2004-09-02 Sankyo Company Limited Benzamidine derivatives
EP1095933A1 (en) * 1999-10-30 2001-05-02 Aventis Pharma Deutschland GmbH Novel N-guanidinoalkylamides, their preparation, their use, and pharmaceutical preparations comprising them
WO2001056989A2 (en) * 2000-02-01 2001-08-09 Cor Therapeutics, Inc. Inhibitors of factor xa
EP1259485B1 (en) 2000-02-29 2005-11-30 Millennium Pharmaceuticals, Inc. BENZAMIDES AND RELATED INHIBITORS OF FACTOR Xa
US6548517B2 (en) * 2000-03-24 2003-04-15 Millennium Pharmaceuticals, Inc. Oxindole inhibitors of factor Xa
AU776053B2 (en) 2000-03-31 2004-08-26 Astellas Pharma Inc. Diazepan derivatives or salts thereof
US6495562B1 (en) 2000-04-25 2002-12-17 Abbott Laboratories Naphthamidine urokinase inhibitors
US6410733B1 (en) 2000-09-11 2002-06-25 Genentech, Inc. Amidine inhibitors of serine proteases
CA2424522C (en) * 2000-11-22 2009-12-29 Yamanouchi Pharmaceutical Co., Ltd. Substituted benzene derivatives or salts thereof
US6710061B2 (en) 2001-03-09 2004-03-23 Ortho-Mcneil Pharamceutical, Inc. Aminopyrrolidine sulfonamides as serine protease inhibitors
JP2004520438A (ja) 2001-03-09 2004-07-08 オーソ−マクニール・フアーマシユーチカル・インコーポレーテツド セリンプロテアーゼインヒビターとしてのアミノピロリジンスルホンアミド
US7312235B2 (en) 2001-03-30 2007-12-25 Millennium Pharmaceuticals, Inc. Benzamide inhibitors of factor Xa
AU2002246336B2 (en) 2001-04-05 2005-05-19 Sankyo Company, Limited Benzamidine derivative
SI1470102T1 (sl) * 2002-01-29 2011-08-31 Merck Serono Sa Substituirani derivati metilen amida kot modulatorji proteinskih tirozinskih fosfataz (ptp)
WO2004048363A1 (ja) 2002-11-22 2004-06-10 Takeda Pharmaceutical Company Limited イミダゾール誘導体、その製造法および用途
US7479502B2 (en) 2002-12-03 2009-01-20 Pharmacyclics, Inc. 2-(2-hydroxybiphenyl-3-yl)-1H-benzoimidazole-5-carboxamidine derivatives as factor VIIA inhibitors
WO2004058728A1 (ja) * 2002-12-24 2004-07-15 Daiichi Pharmaceutical Co., Ltd. 新規なエチレンジアミン誘導体
WO2004113316A1 (en) 2003-05-20 2004-12-29 Genentech, Inc. Benzofuran inhibitors of factor viia
EP1628954A2 (en) 2003-05-20 2006-03-01 Genentech, Inc. Acylsulfamide inhibitors of factor viia
EP1678161B1 (en) 2003-10-09 2009-12-30 Millennium Pharmaceuticals, Inc. Thioether-substituted benzamides as inhibitors of factor xa
TWI396686B (zh) 2004-05-21 2013-05-21 Takeda Pharmaceutical 環狀醯胺衍生物、以及其製品和用法
EP1893572B1 (en) 2004-06-18 2016-12-14 Millennium Pharmaceuticals, Inc. Factor xa inhibitors
US7612089B2 (en) 2004-11-19 2009-11-03 Portola Pharmaceuticals, Inc. Tetrahydroisoquinolines as factor Xa inhibitors
US20060160790A1 (en) * 2004-12-07 2006-07-20 Portola Pharmaceuticals, Inc. Thioureas as factor Xa inhibitors
WO2006063113A2 (en) 2004-12-07 2006-06-15 Portola Pharmaceuticals, Inc. Ureas as factor xa inhibitors
WO2006083003A1 (ja) 2005-02-02 2006-08-10 Ajinomoto Co., Inc. 新規ベンズアミジン化合物
JP5227178B2 (ja) 2005-11-08 2013-07-03 ミレニアム ファーマシューティカルズ， インコーポレイテッド Ｎ−（５−クロロ−２−ピリジニル）−２−［［４−［（ジメチルアミノ）イミノメチル］ベンゾイル］アミノ］−５−メトキシ−ベンズアミド、第Ｘａ因子阻害剤の薬学的な塩および多形体
CA2644369A1 (en) * 2006-03-28 2007-10-04 Novartis Ag Amide derivatives and their application for the treatment of g protein related diseases
AU2007307599A1 (en) 2006-10-12 2008-04-17 Institute Of Medicinal Molecular Design. Inc. N-phenyloxamic acid derivatives
CN101595092B (zh) 2006-11-02 2012-02-01 米伦纽姆医药公司 合成因子xa抑制剂的医药盐的方法
JPWO2008066102A1 (ja) * 2006-11-30 2010-03-11 武田薬品工業株式会社 徐放性製剤
US8633245B2 (en) * 2008-04-11 2014-01-21 Institute Of Medicinal Molecular Design, Inc. PAI-1 inhibitor
EP2311810A4 (en) * 2008-07-11 2012-04-04 Ajinomoto Kk AMIDINE DERIVATIVE
EA015918B1 (ru) 2010-03-03 2011-12-30 Дмитрий Геннадьевич ТОВБИН УРЕТАНЫ, МОЧЕВИНЫ, АМИДЫ И РОДСТВЕННЫЕ ИНГИБИТОРЫ ФАКТОРА Xa
US11679093B2 (en) 2018-06-11 2023-06-20 The Regents Of The University Of Colorado, A Body Corporate 2-naphthimidamides, analogues thereof, and methods of treatment using same
CN117304076B (zh) * 2023-11-28 2024-02-20 苏州大学 一种n-磺酰基脒化合物的制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU527371B2 (en) * 1980-09-16 1983-03-03 Torii & Co., Ltd. Amidine
JPS59139357A (ja) * 1983-01-28 1984-08-10 Torii Yakuhin Kk アミジン誘導体
US4563527A (en) * 1984-07-19 1986-01-07 Torii & Co., Ltd. Amidine compounds
ZA928276B (en) * 1991-10-31 1993-05-06 Daiichi Seiyaku Co Aromatic amidine derivates and salts thereof.

Also Published As

Publication number Publication date
EP0798295A4 (en) 1998-03-04
FI972326A (fi) 1997-06-02
DE69529770T2 (de) 2003-12-24
NO309566B1 (no) 2001-02-19
JP3004362B2 (ja) 2000-01-31
HUT77313A (hu) 1998-03-30
PL320486A1 (en) 1997-09-29
AU688628B2 (en) 1998-03-12
PL184824B1 (pl) 2002-12-31
CA2206532C (en) 2006-07-11
FI115051B (fi) 2005-02-28
DE69529770D1 (de) 2003-04-03
FI972326A0 (fi) 1997-06-02
EP0798295A1 (en) 1997-10-01
PT798295E (pt) 2003-07-31
CN1167484A (zh) 1997-12-10
AU3994295A (en) 1996-06-19
NO972482D0 (no) 1997-05-30
WO1996016940A1 (fr) 1996-06-06
ES2193202T3 (es) 2003-11-01
US5869501A (en) 1999-02-09
TW300888B (es) 1997-03-21
CN1087736C (zh) 2002-07-17
NO972482L (no) 1997-08-01
RU2154633C2 (ru) 2000-08-20
CA2206532A1 (en) 1996-06-06
KR100383161B1 (ko) 2003-12-24
NZ296210A (en) 1998-05-27
ATE233240T1 (de) 2003-03-15
EP0798295B1 (en) 2003-02-26

Similar Documents

Publication Publication Date Title
MX9704059A (es) Derivado de amidinonaftilo novedoso o sal del mismo.
GR3034542T3 (en) 4,5-diaryloxazole derivatives
ES2144421T3 (es) Nuevo derivado tetrapeptidico.
HUT69385A (en) Antiallergic composition for ophthalmic or nasal use
ATE113033T1 (de) Aminosäurederivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel.
HU9501801D0 (en) Lactame-compounds as pharmaceutical active component
MY117092A (en) Chemotherapeutic pyrrolocarbazole derivatives
IL150329A0 (en) 2-(1h-indol-3-yl)-2-oxo-acetamides with antitumor activity
DE69227258D1 (de) Neue Endothelin-Antagonisten und ihre Herstellung
TW340109B (en) Amide derivatives and their therapeutic use
AU696230B2 (en) N-substituted 3-azabicyclo (3.2.0)heptane derivatives, the preparation and use thereof
FR2742048B1 (fr) Utilisation de l'alpha-cyano-beta, beta-diphenylacrylate de 2-ethylhexyle pour ameliorer la stabilite de compositions cosmetiques contenant le p-methyl-benzylidene camphre en association avec un derive de dibenzoylmethane
CA2195747A1 (en) New 3-substituted 3h-2,3-benzodiazepine derivatives, their preparation and use as medicaments
EP1121932A4 (en) DRUGS FOR EYE DISEASES
HRP20010885B1 (en) Ethanesulfonyl-piperidine derivatives
EP0790247A4 (en) TETRAHYDROISOCHINOLINE DERIVATIVES AND MEDICINAL PRODUCTS CONTAINING THEM
EP0657443A4 (en) OPTICALLY ACTIVE CARBOXAMIDE DERIVATIVES.
EP0919554A4 (en) CHINOXALINDION DERIVATIVES SUBSTITUTED BY IMIDAZOLE
TW329388B (en) Intraocular irrigating solution
IE811354L (en) Encainide n-oxide.
AU4965593A (en) Ureido-acetamide derivatives, preparation thereof and drugs containing same
HUP9702315A2 (hu) 4-Hidroxi-piperidin-származékok, előállításuk és alkalmazásuk, a vegyületeket tartalmazó gyógyászati készítmények

Legal Events

Date Code Title Description
FG Grant or registration
MM Annulment or lapse due to non-payment of fees